Previous close | 51.25 |
Open | 51.25 |
Bid | 55.40 |
Ask | 56.60 |
Strike | 70.00 |
Expiry date | 2024-07-19 |
Day's range | 51.25 - 51.25 |
Contract range | N/A |
Volume | |
Open interest | 143 |
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.